Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Growth Rate of the Radiation Oncology Market?
Over the past few years, there has been significant growth in the size of the radiation oncology market. Its progression from $7.99 billion in 2024 to $8.75 billion in 2025, signifying a compound annual growth rate (CAGR) of 9.6%, is noteworthy. Factors contributing to this growth throughout the historic period include an increase in cancer cases, heightened healthcare expenditure, expanded investments in healthcare infrastructure, an aging demographic, and an increasing number of intricate cancer cases.
What Growth Rate Is Forecasted for the Radiation Oncology Market by 2029?
Anticipated robust expansion is predicted in the radiation oncology market in the coming years. It is projected to ramp up to $12.51 billion in 2029 with a compound annual growth rate (CAGR) of 9.3%. The impetus for growth during the projected timeframe can be traced to factors like increasing preference for precise treatment methods, growth of outpatient cancer facilities, rising uptake of treatment planning software, expanded government initiatives towards cancer care, and improved healthcare infrastructure. Foreseeable trends over the forecast period encompass individualized treatment strategies, superior quality imaging, AI-integrated imaging, stereotactic body radiation therapy (SBRT), and advancements in brachytherapy.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=23494&type=smp
Which Key Companies Are Shaping the Future of the Radiation Oncology Market?
Major companies operating in the radiation oncology market are Hitachi Ltd., Siemens Healthineers, Philips Healthcare, GE Healthcare Technologies Inc., Varian Medical Systems, Shimadzu Corporation, Elekta AB, Mirion Technologies, Ion Beam Applications (IBA), Accuray Incorporated, Canon Medical Systems, Eckert & Ziegler BEBIG, ViewRay Inc., MDS Nordion, Mevion Medical Systems, PTW-Freiburg, Toshiba Medical Systems, CivaTech Oncology, ProTom International, Radcal Corporation, ScandiDos.
Which Factors Are Driving Demand in the Radiation Oncology Industry?
The rise in cancer diagnoses is anticipated to stimulate expansion in the radiation oncology sector in the near future. Those diagnosed with cancer, a disorder marked by unregulated cell proliferation and dispersal throughout the body, are referred to as cancer patients. The mounting rate of these diagnoses is predominantly attributed to an increasing prevalence of unhealthy lifestyle habits that contribute to heightened cancer risks. High-energy radiation is employed in radiation oncology to annihilate cancer cells, reduce tumor size, alleviate symptoms, and augment the effectiveness of surgeries and chemotherapy, with advancements in methodology enhancing accuracy and results. For instance, the National Health Service, a UK government agency, reported in October 2024 that 346,217 new cancer cases were reported in 2022, which averages to 948 daily diagnoses, a 5% rise from 329,664 in 2021. Consequently, the surge in cancer patients is fuelling the expansion of the radiation oncology sector.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=23494&type=smp
How Is the Radiation Oncology Market Segmented by Several Divisions?
The radiation oncology market covered in this report is segmented –
1) By Type: External Beam Radiation Therapy, Internal Beam Radiation Therapy
2) By Application: Prostate Cancer, Breast Cancer, Lung Cancer, Head And Neck Cancer, Colorectal Cancer, Cervical Cancer, Gynecological Cancer, Other Applications
3) By End-User: Hospitals, Cancer Research Institutes, Other End-Users
Subsegments:
1) By Internal Beam Radiation Therapy, Brachytherapy, Endocavitary Brachytherapy, Interstitial Brachytherapy, Intraluminal Brachytherapy
2) By External Beam Radiation Therapy, 3D Conformal Radiation Therapy (3DCRT), Intensity-Modulated Radiation Therapy (IMRT), Stereotactic Radiosurgery (SRS), Stereotactic Body Radiation Therapy (SBRT), Image-Guided Radiation Therapy (IGRT)
What are the Emerging Market Trends Driving the Growth of the Radiation Oncology Industry?
Leading businesses in the radiation oncology market are concentrating on the creation of sophisticated radiation therapy systems. These systems combine AI-empowered imaging and adaptive technologies to boost the accuracy of treatments, lessen the adverse effects, and better patient results in varied cancer treatment procedures. Artificial intelligence-enhanced radiotherapy involves the utilization of AI tech to improve several components of radiation therapy, such as treatment planning, imaging, delivery, and supervising. For instance, Elekta, a medical tech firm based in Sweden, unveiled Evo, its newest CT-Linac, in May 2024 with high-definition AI-boosted imaging meant to refine radiation therapy methodologies. This multifaceted system is capable of supporting offline and online adaptive radiation therapy and even enhances the standard image-guided radiation therapy. This system offers medical professionals improved precision and adaptability in customizing treatments for each patient. The aim of this improvement is to promote patient outcomes through the optimization of treatment precision and versatility.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/radiation-oncology-global-market-report
Which Regions Are Driving Growth in the Radiation Oncology Market?
North America was the largest region in the radiation oncology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the radiation oncology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=23494
This Report Delivers Insight On:
1. How big is the radiation oncology market, and how is it changing globally?
2. Who are the major companies in the radiation oncology market, and how are they performing?
3. What are the key opportunities and risks in the radiation oncology market right now?
4. Which products or customer segments are growing the most in the radiation oncology market?
5. What factors are helping or slowing down the growth of the radiation oncology market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
